Re-establishing indwelling pleural catheter patency with alteplase after failure of streptokinase
© 2020 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology..
Indwelling pleural catheter (IPC) has revolutionized the management of malignant pleural effusion (MPE). IPC is relatively safe, although complications can occur. We report a 53-year-old woman with stage IVA lung adenocarcinoma and recurrent MPE. Two months post insertion, the IPC was blocked with residual effusion and presence of new loculations. Attempts to restore patency with six doses of intrapleural (IP) streptokinase failed. She was referred to our centre for further management. We used a single dose of 2.5 mg IP alteplase which was successful in establishing patency of the IPC and draining the effusion. This case highlights the safety and efficacy of IP alteplase via IPC following a failed instillation of streptokinase.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
---|---|
Enthalten in: |
Respirology case reports - 8(2020), 7 vom: 21. Okt., Seite e00639 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Faisal, Mohamed [VerfasserIn] |
---|
Links: |
---|
Themen: |
Alteplase |
---|
Anmerkungen: |
Date Revised 29.03.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1002/rcr2.639 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM313498067 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM313498067 | ||
003 | DE-627 | ||
005 | 20240329234128.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/rcr2.639 |2 doi | |
028 | 5 | 2 | |a pubmed24n1354.xml |
035 | |a (DE-627)NLM313498067 | ||
035 | |a (NLM)32774860 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Faisal, Mohamed |e verfasserin |4 aut | |
245 | 1 | 0 | |a Re-establishing indwelling pleural catheter patency with alteplase after failure of streptokinase |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 29.03.2024 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2020 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology. | ||
520 | |a Indwelling pleural catheter (IPC) has revolutionized the management of malignant pleural effusion (MPE). IPC is relatively safe, although complications can occur. We report a 53-year-old woman with stage IVA lung adenocarcinoma and recurrent MPE. Two months post insertion, the IPC was blocked with residual effusion and presence of new loculations. Attempts to restore patency with six doses of intrapleural (IP) streptokinase failed. She was referred to our centre for further management. We used a single dose of 2.5 mg IP alteplase which was successful in establishing patency of the IPC and draining the effusion. This case highlights the safety and efficacy of IP alteplase via IPC following a failed instillation of streptokinase | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Alteplase | |
650 | 4 | |a blocked | |
650 | 4 | |a indwelling pleural catheter | |
650 | 4 | |a malignant pleural effusion | |
650 | 4 | |a streptokinase | |
700 | 1 | |a Nurhanis, Siti |e verfasserin |4 aut | |
700 | 1 | |a Nik Abeed, Nik Nuratiqah |e verfasserin |4 aut | |
700 | 1 | |a Ng, Boon Hau |e verfasserin |4 aut | |
700 | 1 | |a Ban, Andrea Yu-Lin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Respirology case reports |d 2013 |g 8(2020), 7 vom: 21. Okt., Seite e00639 |w (DE-627)NLM244269440 |x 2051-3380 |7 nnns |
773 | 1 | 8 | |g volume:8 |g year:2020 |g number:7 |g day:21 |g month:10 |g pages:e00639 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/rcr2.639 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 8 |j 2020 |e 7 |b 21 |c 10 |h e00639 |